GlobalData on MSN12h
Novadip’s bone graft material unifies fractures in 100% of patients
Novadip Biosciences’s bone grafting material NVDX3 has seen all patients achieve bone fracture union in a 12-month Phase ...
BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
Underscores high unmet need for a therapeutic alternative to opioids and surgical interventions –– Reflects positive preliminary Phase 2 Safety ...
Cosmetics Business18h
Gattefossé pushes further its approach of upcycling
Pursuing the ambitious objectives of its CSR policy, the French-heritage cosmetic ingredients maker Gattefossé, reinforces ...
Cosmetics Business6h
Push back the limits of cell aging
SILAB presents new efficacy studies on LONGEVICELL, a natural anti-aging active ingredient obtained from myrtle leaves and ...
Epithelial stem cell ancestors for hair follicle formation
What if the secret to curing baldness has been hiding in your hair all along? University of Virginia School of Medicine ...
Gut microbiome changes linked to multiple sclerosis, study finds
The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has ...
Zacks Small Cap Research on MSN15h
NRXBF Pushing into US Market
NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...
scientistlive.com20h
Cytokines in stem cells and organoids: A paradigm shift in drug discovery
The integration of cytokines into stem cell and organoid research has significantly advanced drug discovery by enabling more ...